Department of Chemical Engineering

Research output

Research output per year 1973 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 5717 Article
• 581 Conference contribution
• 239 Chapter
• 83 Patent
• 487 More
  • 67 Review article
  • 58 Other
  • 51 Data set/Database
  • 47 Paper
  • 36 Meeting Abstract
  • 35 Poster
  • 30 Other contribution
  • 23 Editorial
  • 16 Book
  • 16 Doctoral Thesis
  • 15 Commentary/debate
  • 15 Conference article
  • 15 Letter
  • 14 Abstract
  • 11 Preprint
  • 9 Commissioned report
  • 6 Scholarly edition
  • 5 Anthology
  • 4 Literature review
  • 3 Other report
  • 3 Entry for encyclopedia/dictionary
  • 2 Foreword/postscript
  • 2 Master's Thesis
  • 1 Short survey
  • 1 Special issue
  • 1 Exhibition
  • 1 Working paper

Research output per year

Research output per year

Search results

• 2022

  A phase II study to evaluate the safety and efficacy of IMM-101 in combination with checkpoint inhibitors in patients with advanced melanoma: Final results of the IMM101-015 trial.

  Fusi, A., Gupta, A., Lorigan, P., Smith, P. & Bowles, M., 1 Jun 2022, In: Journal of Clinical Oncology. 40, 16, 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC)

  Horne, A., Ali, A., Brown, S., Butterworth, K., Chalmers, A., Clipson, A., Collinson, F., Dive, C., Faivre-Finn, C., Forster, M., Franks, K., Gilbert, A., Hanna, G., Hannaway, N., Harrow, S., Hartley, J., Hiley, C., Jones, R., Kendall, J. & Krebs, M. & 11 others, Mallison, G., O’Connor, J., Oughton, J., Phillip, R., Rothwell, D., Salem, A., Sebag-Montefiore, D., Shaw, P., Walls, G., Young, R. & Greystoke, A., Mar 2022, In: Lung Cancer. 165, p. S69-S70 11 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

  • Non Small Cell Lung Cancer 100%
  • Malignant Neoplasm 33%
  • Combination Therapy 33%
  • Biological Marker 33%
  • Durvalumab 33%

• DETECTION phase II/III trial: Circulating tumor DNA-guided therapy for stage IIB/C melanoma after surgical resection.

  Lee, R., Rothwell, D., Jackson, R., Smith, N., Wong, S., Kelso, N., Burghel, G., Hewitt, C., Clarke, H., Mitchell, J., Jones, K., Muinonen-Martin, A., Turajlic, S., Corrie, P., Marais, R., Middleton, M., Dawson, S., Sandhu, S., Dive, C. & Lorigan, P., 1 Jun 2022, In: Journal of Clinical Oncology. 40, 16, 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• To what extent, how and how robustly have patientreported outcome measures (PROMs) been investigated as prognostic factors in non-small cell lung cancer: a scoping review

  Liao, K., Wang, T., Coomber-Moore, J., Wong, D., Gomes, F., Faivre-Finn, C., Sperrin, M., Yorke, J. & Van der Veer, S., Nov 2022, In: Quality of Life Research . 31, p. S93-S94 2 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2021

  Median Time to Diagnosis for Most Childhood Cancers is Longer in Low/Middle-Income Countries Compared to High-Income Countries: Results of a Systematic Review and Meta-Analysis

  Faruqui, N., Kontopantelis, E., Joshi, R., Martiniuk, A., Venchiarutti, R., Gupta, S. & Arora, R., Dec 2021, In: Pediatric Blood & Cancer. 67, p. S35-S36

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2019

  SELPAC: A 3 arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel (PT) in metastatic uveal melanoma (UM)

  Nathan, P., Needham, A., Corrie, P. G., Danson, S., Evans, J., Ochsenreither, S., Kumar, S., Goodman, A., Larkin, J. M. G., Karydis, I., Steven, N. M., Lorigan, P., Plummer, R., Patel, P., Shaw, H. M., Leyvraz, S., Rawcliffe, C., Psarelli, E. E., Handley, L. & Sacco, J. J., Oct 2019, In: Annals of Oncology. 30

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2017

  Alpha-pinene isomerization over silica supported heteropolyacids

  Frattini, L., Isaacs, M., Parlett, C., Wilson, K., Kyriakou, G. & Lee, A., 2 Apr 2017, In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 253

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Design of hierarchical photocatalyst for waste water treatment

  Barbero, B., Parlett, C., Lee, A. & Wilson, K., 2 Apr 2017, In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 253

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Modified DTPA ligand systems for simplified trivalent actinide- lanthanide separations based on the TALSPEAK process

  Jones, J., Langford, M., Geist, A., Panak, P., Kaden, P., Adam, C., Adam, N., Sharrad, C., Martin, L. & Natrajan, L., 2 Apr 2017, In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 253

  Research output: Contribution to journal › Meeting Abstract

• Nanostructured promoted titania photocatalysts for solar fuels

  Trofimovaite, R., Parlett, C., Isaacs, M., Kumar, S. & Lee, A., 2 Apr 2017, In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 253

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Pt-catalysed hydrodeoxygenation of lignin monomers: Understanding of factors affecting the catalyst performance

  Shivhare, A., Lee, A., Wilson, K., Hunns, J., Parlett, C. & Isaacs, M., 2 Apr 2017, In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 253

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Separations in advanced nuclear fuel cycles

  Sharrad, C., Edwards, A., Lambert, H., Bikbajeva, Z., Foster, R., Kerry, T., Whitehead, R. & Harwood, L., 2 Apr 2017, In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 253

  Research output: Contribution to journal › Meeting Abstract
• 2016

  Application of sequencing, liquid biopsies and patient-derived xenografts for personalized medicine in melanoma (Poster ref 836, EACR24 Poster Sessions, EJC 61, Suppl 1 [2016] S9-S218).

  Girotti, M. R., Gremel, G., Lee, R., Galvani, E., Rothwell, D., Mandal, A. K., Lim, K. H. J., Saturno, G., Furney, S. J., Baenke, F., Pedersen, M., Smith, M., Fusi, A., Dhomen, N., Brady, G., Lorigan, P., Dive, C. & Marais, R., Jul 2016, In: European Journal of Cancer. 61, p. S193

  Research output: Contribution to journal › Meeting Abstract › peer-review

• The Development of an Umbrella Trial (PLATO) to Address Radiation Therapy Dose Questions in the Locoregional Management of Squamous Cell Carcinoma of the Anus

  Sebag-Montefiore, D., Adams, R., Bell, S., Berkman, L., Gilbert, D. C., Glynne-Jones, R., Goh, V., Gregory, W., Harrison, M., Kachnic, L. A., Lee, M. T., McParland, L., Muirhead, R., O'Neill, B. D., Hutchins, G. G., Rao, S., Renehan, A., Smith, A., Velikova, G. & Hawkins, M. A., 1 Oct 2016, In: International Journal of Radiation Oncology Biology Physics. 96, 2, p. E164-E165

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2015

  Flexible Cu2(pzdc)2L [L= dipyridyl-based ligands] porous coordination polymers: Hysteretic adsorption and diffusion kinetics of CO2 and CH4

  Chen, H., Riascos-Rodriguez, K., Marcano-Gonzalez, M. & Hernandez-Maldonado, A., 16 Aug 2015, In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 250

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Injectable Peptide Hydrogel for the Treatment of Barrett's Oesophagus

  Kumar, D., Workman, V. L., Castillo Diaz, L. A., Rose, F. R. A. J., Miller, A., Saiani, A. & Gough, J. E., 2015, In: European Cells and Materials. 29, Supplement 3, p. 73 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2014

  Alkali- and nitrate-free synthesis of highly active Mg-Al hydrotalcite-coated alumina for FAME production

  Manayil, J. C., Creasey, J. J., Chieregato, A., Parlett, C. M. A., Wilson, K. C. & Lee, A. F., 10 Aug 2014, In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 248

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Rational design of heterogeneous catalysts for the selective aerobic oxidation of alcohols

  Lee, A. F., Parlett, C. M. A., Wilson, K., Zeinalipour-Yazdi, C. D. & Willock, D. J., 10 Aug 2014, In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 248

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2013

  Alpha-1-antitrypsin phenotype and endotoxin exposure are related to BHR but not to change in lung function in a 15 year follow up of young Danish farmers

  Sigsgaard, T., Bolund, A. C. S., Basinas, I., Elholm, G., Omland, O., Miller, M. & Schluenssen, V., 1 Sept 2013, In: European Respiratory Journal. 42

  Research output: Contribution to journal › Meeting Abstract › peer-review

  • Alpha 1 Antitrypsin 100%
  • Matrix 100%
  • Spirometry 100%
  • Metformin Plus Rosiglitazone 25%

• Development of a simplified soft-donor technique for trivalent actinide-lanthanide separations

  Langford, M. H., Natrajan, L. S., Sharrad, C. A., Martin, L. R. & Grimes, T. S., 7 Apr 2013, In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 245, 115-IEC.

  Research output: Contribution to journal › Meeting Abstract

• Enhanced selective aerobic alcohol oxidation through nanoengineered catalyst supports

  Parlett, C. M. A., Lee, A. F., Wilson, K., Bruce, D. W., Hondow, N. S. & Newton, M. A., 8 Sept 2013, In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 246

  Research output: Contribution to journal › Meeting Abstract › peer-review

  • Nanoparticle 100%
  • Mesoporous Silica 100%
  • Catalyst Support 100%
  • Mesopore 66%
  • Kinetic Study 50%

• Glycerol hydrogenolysis using laboratory prepared ruthenium supported copper chromite catalyst (Ru/Cu-Cr)

  Asuquo, E. D., Kozhevnikov, I. & Alhanash, A., 8 Sept 2013, In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 246

  Research output: Contribution to journal › Meeting Abstract › peer-review

• How farming exposure affects lung development in young adults

  Bolund, A. C. S., Basinas, I., Elholm, G., Miller, M. R., Omland, O., Schlunssen, V. & Sigsgaard, T., 1 Sept 2013, In: European Respiratory Journal. 42, Supplement 57, p. 1556 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

  • Adverse Effects 100%
  • Young Adults 100%
  • Longitudinal Study 100%
  • Spirometry 100%
  • Endotoxin 100%

• Phase I Clinical Trial Assessing the Mek Inhibitor Selumetinib (azd6244; Arry-142886) with Concomitant Thoracic Radiotherapy (rt) in Patients with Stage Iii-iv Non Small Cell Lung Cancer (nsclc)

  Fusi, A., Blackhall, F., Koh, P., Dive, C., Stratford, I., Williams, K., Bayman, N., Ashcroft, L., Coyne, T., Falk, S. & Faivre-Finn, C., Nov 2013, In: Journal of Thoracic Oncology. 8, p. S553-S554 2 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Understanding molecular speciation of actinides in solvent extraction processes

  Griffiths, T. L., Tucker, K. L., Sharrad, C. A., Martin, L. R. & Kaden, P., 7 Apr 2013, In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 245

  Research output: Contribution to journal › Meeting Abstract
• 2012

  Efficacy and safety of conventional-dose lenalidomide followed by low-dose maintenance lenalidomide for relapsed/refractory mantle cell lymphoma (MCL): updated results from a UK phase II study

  Eve, H. E., Carey, S., Richardson, S. J., Heise, C. C., Mamidipudi, V., Shi, T., Radford, J. A., Auer, R. L., Bullard, S. H. & Rule, S. A. J., 2012, In: British Journal of Haematology. 157, 1, p. 14-14 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Human hair follicle epithelial progenitor cells express clock genes in situ: Regulation by TRH

  Hardman, J., Al-Nuaimi, Y., Baier, G., Haslam, I. & Paus, R., Sept 2012, In: Journal of Investigative Dermatology. 132, S2, p. S104-S110

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2011

  CONSEQUENCES OF NANOSCALE ENERGY DEPOSITION AROUND HEAVY ATOM NANOPARTICLES: IMPLICATIONS FOR RADIOTHERAPY

  McMahon, S., Hyland, W., Muir, M., Coulter, J., Jain, S., Butterworth, K., Schettino, G., Dickson, G., Hounsell, A. R., O'Sullivan, J., Prise, K. & Currell, F., May 2011, In: Radiotherapy and Oncology. 99, Supplement 1, p. S182-S182

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2010

  Tailored Pd nanocatalysts for the selective aerobic oxidation of allylic alcohols

  Ellis, C., Lee, A., Wilson, K., Lim, T., Newton, M. & Parlett, C., 22 Aug 2010, In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 240, 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• The Role of Hydrophobicity in Peptide-Membrane Interactions: Insights Through Coarse-Grained Molecular Dynamics Simulations

  Gkeka, P. & Sarkisov, L., Jan 2010, In: BIOPHYSICAL JOURNAL. 98, 3, p. 82A

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2003

  MALT1 expression in normal and neoplastic lymphoid tissues: Strong expression characterizes t(14;18)(q32;q21) of MALT lymphoma.

  Ye, H., Liu, H., Shirali, S., Chott, A., Streubel, B., Siebert, R., Gesk, S., Radford, J., Banerjee, S., Isaacson, P., Dogan, A. & Du, M., 2003, In: Blood. 102, 11, p. 892A-892A 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Non-Hodgkin's lymphoma of the ocular adnexae; Three decades of experience at a single UK centre.

  Armstrong, A., Chapman, J., Banerjee, S., Noble, J., Leatherbarrow, B., Ryder, W., Bonshek, R., Deakin, D., Cowan, R. & Radford, J., Jul 2003, In: British Journal of Cancer. 88, Suppl. 1, p. S65 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2000

  Copy number gain at 12q12-14 may be associated with poor outcome following the transformation event in non-Hodgkin's lymphoma

  Hough, R., Goepel, J., Alcock, H., Hancock, B., Lorigan, P. & Hammond, D., Jul 2000, In: British Journal of Cancer. 83, Supplement 1, p. 82 1 p., P214.

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 1999

  Identification of genomic copy number changes associated with the transformation event in non-Hodgkin's lymphoma, using comparative genomic hybridization

  Hough, R. E., Geopel, J. R., Alcock, H. E., Hancock, B. W., Lorigan, P. C. & Hammond, D. W., Mar 1999, In: Proceedings of the American Association for Cancer Research Annual Meeting. 40, p. 541

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 1997

  The VEDex regimen: An effective and well tolerated palliative treatment for relapsed non-Hodgkin's lymphoma (NHL) [BJC]

  El-Helw, L., Lorigan, P. C., Coleman, R. E. & Hancock, B. W., 1997, In: British Journal of Cancer. 76 , Supplement 1, p. 51 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 1995

  Etoposide and actinomycin D (EA) for methotrexate (MTX) resistant, low risk, persistent gestational trophoblastic disease (GTD) and EA with MTX (MEA) for high risk GTD

  Lorigan, P., Nevin, J., Radstone, C., Coleman, R. & Hancock, B., Nov 1995, In: European Journal of Cancer. 31A, Supplement 5, p. 1168-1168 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review